Document:

EX-10.7

 Exhibit 10.7 

SECOND AMENDMENT TO 

MULTI-TENANT INDUSTRIAL/COMMERCIAL LEASE (NET) 

(Roselle Technology Park) 

THIS SECOND AMENDMENT TO MULTI-TENANT INDUSTRIAL/ COMMERCIAL LEASE (NET) dated November 19, 2015 (this “Second
Amendment”) is entered into by and between BRS-TUSTIN SAFEGUARD ASSOCIATES II, LLC, a Delaware limited liability company (“Lessor”), and PFENEX INC., a Delaware corporation (“Lessee”), with reference to the
following: 
 R E C I T A L S 

WHEREAS, Lessor and Lessee entered into that certain Multi-Tenant Industrial/Commercial Lease (Net) dated June 22,
2010 (the “Original Lease”), as amended by that certain First Amendment to Multi-Tenant Industrial/Commercial Lease (Net) dated September 4, 2014 by and between Lessor and Lessee (collectively, the “Lease”), for the lease of
certain premises (the “Existing Premises”), consisting of approximately 30,148 rentable square feet comprised of (a) approximately 22,833 rentable square feet located at 10790 Roselle Street, San Diego, California (the “10790
Building”), and (b) approximately 7,315 rentable square feet, commonly known as Suite 102 located at 10788 Roselle Street, San Diego, California (the “10788 Building”). All capitalized terms used herein and not otherwise defined
herein shall have the meanings ascribed to such terms in the Lease; and 
 WHEREAS, Lessor and Lessee desire by this
Second Amendment to amend the Lease in order to, among other things, (a) expand the Existing Premises leased by Lessee under the Lease to include certain premises consisting of (i) approximately 6,937 rentable square feet, commonly known as Suite
101, located at the 10788 Building (“Suite 101”), and (ii) approximately 9,874 rentable square feet, commonly known as Suite 103, located at the 10788 Building (“Suite 103”); (b) provide for the Base Rent to be paid by Lessee for
Suite 101 and Suite 103 during the remainder of the term of the Lease; and (c) further amend, modify and supplement the Lease as set forth herein. 

NOW, THEREFORE, in consideration of the Existing Premises, Suite 101 and Suite 103 and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, Lessor and Lessee hereby agree as follows: 

1.        Recitals. The Recitals set forth above are incorporated herein
as though set forth in full herein. 
 2.        Expansion; Description of
Premises and the Building. Effective as of March 1, 2016 (the “Suite 101 Commencement Date”), Lessor shall lease to Lessee, and Lessee shall lease from Lessor, Suite 101 as outlined on Exhibit A attached hereto and
incorporated herein by this reference, upon all of the terms and conditions of the Lease except as otherwise set forth herein. Therefore, the Lease is hereby amended such that, from and after the Suite 101 Commencement Date, all references in the
Lease to the “Premises” shall mean and refer to the entirety of the space in the Existing Premises and Suite 101, which is approximately thirty seven 

  

							
		 	1	 	Lessor’s Initials:	 	 MB

		 		 	Lessee’s Initials:	 	 BL

 
thousand eighty five (37,085) square feet. Effective as of June 1, 2016 (the “Suite 103 Commencement Date”), Lessor shall lease to Lessee, and Lessee shall lease from Lessor, Suite
103 as outlined on Exhibit B attached hereto and incorporated herein by this reference, upon all of the terms and conditions of the Lease except as otherwise set forth herein. Therefore, the Lease is hereby amended such that, from and after the
Suite 103 Commencement Date, all references in the Lease to the “Premises” shall mean and refer to the entirety of the space in the Existing Premises, Suite 101 and Suite 103, which is approximately forty six thousand nine hundred fifty
nine (46,959) square feet. 
 3.        Base Rent for Suite 101.
In accordance with the terms of the Lease and in addition to paying all other amounts due under the Lease, including, without limitation, Lessee’s Share of Common Area Operating Expenses in accordance with Section 7 below, Lessee shall pay
monthly Base Rent for Suite 101 commencing on the Suite 101 Commencement Date and continuing for the remainder of the term of the Lease in accordance with the following schedule: 

 

			
	 Period
	  	 Monthly Base Rent

	March 1, 2016 – February 28, 2017*	  	$7,977.55
	March 1, 2017 – February 28, 2018	  	$8,216.88
	March 1, 2018 – February 28, 2019	  	$8,463.38
	March 1, 2019 – February 29, 2020	  	$8,717.28
	March 1, 2020 – February 28, 2021	  	$8,978.80
	March 1, 2021 – February 28, 2022	  	$9,248.17
	March 1, 2022 – February 28, 2023	  	$9,525.61
	March 1, 2023 – February 29, 2024	  	$9,811.38
	March 1, 2024 – March 31, 2024	  	$10,105.72

			
	* Subject to abatement of monthly Base Rent for Suite 101 for the four (4) month period commencing on April 1, 2016 and ending on July 31, 2016 pursuant to Section 4
below.

 4.        Abatement of Four (4) Months of Base
Rent for Suite 101. Notwithstanding anything to the contrary contained in the Lease, Lessor and Lessee hereby agree that for the four (4) month period commencing on April 1, 2016 and ending on July 31, 2016, the monthly Base Rent
due for Suite 101 (i.e., $7,977.55) shall be fully abated; provided, that (i) at no time is Lessee in Breach under the Lease, and (ii) Lessee agrees that notwithstanding the foregoing monthly Base Rent abatement, Lessee shall observe and perform all
of the other terms, covenants and provisions set forth in the Lease and this Second Amendment, including, but not limited to, payment of monthly Base Rent for the Existing Premises, Suite 103 and Lessee’s Share of Common Area Operating
Expenses. 
 5.        Base Rent for Suite 103. In accordance with the
terms of the Lease and in addition to paying all other amounts due under the Lease, including, without limitation, Lessee’s Share of Common Area Operating Expenses in accordance with Section 7 below, Lessee shall pay monthly Base Rent for Suite
103 commencing on the Suite 103 Commencement Date and continuing for the remainder of the term of the Lease in accordance with the following schedule: 
  

			
	 Period
	  	 Monthly Base Rent

	June 1,2016 – May 31, 2017*	  	$13,823.60
	June 1, 2017 – May 31, 2018	  	$14,238.31
	June 1, 2018 – May 31, 2019	  	$14,665.46
	June 1, 2019 – May 31, 2020	  	$15,105.42
	June 1, 2020 – May 31, 2021	  	$15,558.58
	June 1, 2021 – May 31, 2022	  	$16,025.34
	June 1, 2022 – May 31, 2023	  	$16,506.10
	June 1, 2023 – March 31, 2024	  	$17,001.28

			
	* Subject to abatement of monthly Base Rent for Suite 103 for the four (4) month period commencing on July 1, 2016 and ending on October 31, 2016 pursuant to Section 6
below

  

							
		 	2	 	Lessor’s Initials:	 	 MB

		 		 	Lessee’s Initials:	 	 BL

 6.        Abatement of Four (4)
Months of Base Rent for Suite 103. Notwithstanding anything to the contrary contained in the Lease, Lessor and Lessee hereby agree that for the four (4) month period commencing on July 1, 2016 and ending on October 31, 2016, the
monthly Base Rent due for Suite 103 (i.e., $13,823.60) shall be fully abated; provided, that (i) at no time is Lessee in Breach under the Lease, and (ii) Lessee agrees that notwithstanding the foregoing monthly Base Rent abatement, Lessee shall
observe and perform all of the other terms, covenants and provisions set forth in the Lease and this Second Amendment, including, but not limited to, payment of monthly Base Rent for the Existing Premises, Suite 101 and Lessee’s Share of Common
Area Operating Expenses. 
 7.        Lessee’s Share. In addition
to paying all other amounts due under the Lease, Lessee shall pay Lessee’s Share of Common Area Operating Expenses for Suite 101 and Suite 103 in accordance with Paragraph 4 of the Lease. For such purpose, effective as of (a) the Suite 101
Commencement Date, “Lessee’s Share” set forth in Paragraph 1.7 of the Original Lease shall be fifty one and 55/100 percent (51.55%) as to the Industrial Center, one hundred and No/100 percent (100%) as to the 10790 Building, and forty
six and 99/100 percent (46.99%) as to the 10788 Building, and (b) the Suite 103 Commencement Date, “Lessee’s Share” set forth in Paragraph 1.7 of the Original Lease shall be sixty five and 27/100 percent (65.27%) as to the Industrial
Center, one hundred and No/100 percent (100%) as to the 10790 Building, and seventy nine and 54/100 percent (79.54%) as to the 10788 Building. 

8.        Condition of Suite 101, Suite 103 and the Existing Premises.
Lessee hereby acknowledges that it has had an opportunity to investigate and inspect the condition of Suite 101 and Suite 103 and the suitability of same for Lessee’s purposes, and, except as otherwise provided in the Lease and this Second
Amendment, Lessee does hereby waive and disclaim any objection to, cause of action based upon, or claim that its obligations hereunder should be reduced or limited because of the condition of Suite 101 or Suite 103 or the suitability of same for
Lessee’s purposes. Except as otherwise provided in the Lease and this Second Amendment, Lessee acknowledges that neither Lessor nor any agent nor any employee of Lessor has made any representations or warranty with respect to Suite 101 or Suite
103 or with respect to the suitability of Suite 101 or Suite 103 for the conduct of Lessee’s business and Lessee expressly warrants and represents that Lessee has relied solely on its own investigation and inspection of Suite 101 and Suite 103
in its decision to enter into this Second Amendment and let Suite 101 and Suite 103 in an “as is” condition. No promise of Lessor to alter, remodel, repair, or improve the Existing Premises, Suite 101 or Suite 103 and no representation,
express or implied, respecting any matter or thing relating to the Existing Premises, Suite 101 or Suite 103 has been made to Lessee by Lessor or its broker or sales agent other than as 

  

							
		 	3	 	Lessor’s Initials:	 	 MB

		 		 	Lessee’s Initials:	 	 BL

 
may be contained herein or in the Lease. Notwithstanding the foregoing, Suite 101 and Suite 103 shall be delivered to Lessee following the mutual execution and delivery of this Second Amendment
(the “Delivery Date”) with the existing roof, heating, ventilation and air-conditioning (“HVAC”), electrical, lighting and plumbing systems in good working order (except as otherwise provided in the following sentences) and
Lessor warrants that the such systems shall continue to operate in good working order for the period ending on the ninetieth (90th) day after the Delivery Date (the “Suites 101 and 103
Warranty Period”), except to the extent such failure in any such systems to operate in good working order is caused by Lessee’s use or alterations to Suite 101 or Suite 103 or failure to properly maintain the systems as required by the
Lease, as amended by this Second Amendment. Lessee acknowledges and agrees that Suite 103 will be delivered to Lessee on the Delivery Date in shell condition and that such warranty shall only apply to the existing roof and lighting system in Suite
103. Lessee further acknowledges and agrees that there are no HVAC distribution or plumbing systems currently existing in Suite 103 and that such systems shall be installed by Lessee as part of the Suite 103 Improvements (as defined below). If a
non-compliance with the foregoing warranty exists at any time prior to the expiration of the Suites 101 and 103 Warranty Period, Lessor shall, except as otherwise provided in the Lease or this Second Amendment, promptly after receipt of written
notice from Lessee setting forth with specificity the nature and extent of such non-compliance, commence and diligently pursue to completion the required remedial actions to rectify same at Lessor’s expense. If Lessee does not give Lessor
written notice of a non-compliance on or before the expiration of the Suites 101 and 103 Warranty Period, correction of that non-compliance shall be as set forth in the Lease, as modified by this Second Amendment. Lessor hereby informs Lessee that
the Existing Premises, Suite 101 and Suite 103 have not undergone inspection by a Certified Access Specialist (“CASp”). The foregoing verification is included in this Second Amendment solely for the purpose of complying with California
Civil Code Section 1938 and shall not in any manner affect Lessor’s and Lessee’s respective responsibilities for compliance with construction-related accessibility standards as provided under the Lease. Lessee hereby waives any and all
rights under and benefits of California Civil Code Section 1938 and acknowledges that the 10788 Building, 10790 Building, the Existing Premises, Suite 101, Suite 103 or the Industrial Center have not undergone inspection by a CASp. 

9.        Improvement Allowances for Suite 101 and Suite 103.
Lessor shall provide to Lessee (a) an improvement allowance to pay Lessee’s costs and expenses (“Suite 101 Improvement Costs”) incurred by Lessee in design, permitting and construction of certain permanently affixed improvements
(including, without limitation, costs of space planners, architects, and project managers, and costs of painting and carpeting) to Suite 101 (the “Suite 101 Improvements”) up to an aggregate maximum amount of Thirty Four Thousand Six
Hundred Eighty Five and No/100 Dollars ($34,685.00) (the “Suite 101 Allowance”), and (b) an improvement allowance to pay Lessee’s costs and expenses (“Suite 103 Improvement Costs”) incurred by Lessee in design, permitting
and construction of certain permanently affixed improvements (including, without limitation, costs of space planners, architects, and project managers, and costs of painting and carpeting) to Suite 103 (the “Suite 103 Improvements”) up to
an aggregate maximum amount of One Hundred Forty Eight Thousand One Hundred Ten and No/100 Dollars ($148,110.00) (the “Suite 103 Allowance”). Lessor shall pay portions of the Suite 101 Allowance and the Suite 103 Allowance to Lessee from
time to time, but not more often than once a month, within thirty (30) days of Lessor’s receipt of invoices therefor and unconditional mechanics lien waivers for all work evidenced by the current month’s invoices. Lessor shall be paid a
construction management fee (the “Construction 

  

							
		 	4	 	Lessor’s Initials:	 	 MB

		 		 	Lessee’s Initials:	 	 BL

 
Management Fee”) equal to three percent (3%) of the amount of the Suite 101 Allowance and the Suite 103 Allowance disbursed by Lessor. The Construction Management Fee shall be included in
the Suite 101 Improvement Costs and the Suite 103 Improvement Costs and Lessor shall deduct the Construction Management Fee from the Suite 101 Allowance and Suite 103 Allowance, as applicable. If Lessee has not requested payment of any portion of
the Suite 101 Allowance or the Suite 103 Allowance by December 31, 2016, then Lessee shall not be entitled to any further payments of, and shall not have any further right to, such portion of the Suite 101 Allowance or the Suite 103 Allowance,
as applicable. Except as otherwise expressly provided herein, the Suite 101 Improvements and the Suite 103 Improvements shall be subject to all of the applicable terms and provisions of the Lease, including, without limitation, all of the
requirements for Alterations set forth in Paragraph 7.3 of the Original Lease; provided, however, that (i) Lessor shall not require Lessee to obtain any lien or completion bond or similar security in connection with the Suite 101 Improvements or the
Suite 103 Improvements, (ii) Lessee shall not be required to pay or reimburse Lessor for any costs and expenses in connection with the Suite 101 Improvements or the Suite 103 Improvements other than the Construction Management Fee, and (iii) at the
time of Lessor’s approval of the plans for the Suite 101 Improvements and the Suite 103 Improvements, Lessor will inform Lessee whether Lessee will be required to remove or restore any of the Suite 101 Improvements or Suite 103 Improvements at
the expiration or earlier termination of Lessee’s lease of Suite 101 or Suite 103, as applicable. Lessee will be responsible for paying all Suite 101 Improvement Costs in excess of the Suite 101 Allowance and all Suite 103 Improvement Costs in
excess of the Suite 103 Allowance, if any. In no event shall Lessor be obligated to make disbursements pursuant to this Section in a total amount which exceeds the Suite 101 Allowance or the Suite 103 Allowance, as applicable. In the event that the
actual Suite 101 Improvement Costs are less than the Suite 101 Allowance or the actual Suite 103 Improvement Costs are less than the Suite 103 Allowance, Lessee shall not be entitled to any credit against rent for any unused portion of the Suite 101
Allowance or the Suite 103 Allowance; provided, however, that Lessee shall be entitled to use any unused portion of the Suite 101 Allowance to pay Suite 103 Improvement Costs. All improvements paid for with the Suite 101 Allowance or the Suite 103
Allowance shall be deemed Lessor’s property under the terms of the Lease. Except as specifically set forth in this Second Amendment and/or the Lease, Lessor shall not be obligated to provide or pay for any improvement work or services related
to the improvement of the Existing Premises, Suite 101 or Suite 103. 
 10.      Early
Occupancy. Lessee shall be entitled to early occupancy of Suite 101 and Suite 103 following the mutual execution and delivery of this Second Amendment and continuing until the Suite 101 Commencement Date or the Suite 103 Commencement Date,
as applicable (the “Early Occupancy Period”); provided, however, that Lessee complies with all of the terms and conditions of the Lease, as amended by this Second Amendment, including the obligation to pay for all utilities and services
supplied to Suite 101 and Suite 103 in accordance with Paragraph 11 of the Original Lease but excluding any covenant to pay Base Rent or Lessee’s Share of Common Area Operating Expenses with respect to Suite 101 or Suite 103 during the Early
Occupancy Period. If any such utilities are not separately metered to Suite 101 or Suite 103 or separately billed to Suite 101 or Suite 103, Lessee shall reimburse Lessor a reasonable proportion to be determined by Lessor of all such charges jointly
metered or billed with other premises in the 10788 Building within thirty (30) days of demand from Lessor. Notwithstanding the foregoing, Lessee shall not be entitled to early occupancy until Lessee has delivered the additional Security Deposit as
required under 

  

							
		 	5	 	Lessor’s Initials:	 	 MB

		 		 	Lessee’s Initials:	 	 BL

 
Section 12 below and evidence of insurance coverage covering Suite 101 or Suite 103, as applicable, pursuant to Paragraph 8 of the Original Lease. Lessee shall hold Lessor harmless from and
indemnify, protect and defend Lessor against any loss or damage to Suite 101, Suite 103, the 10788 Building or the Industrial Center and against injury to any persons to the extent caused by Lessee’s actions pursuant to this Section. 

11.      Use of Suite 101 and Suite 103. Suite 101 and Suite 103 shall be
used by Lessee solely for the Permitted Use and for no other use or purpose without Lessor’s prior written consent. 

12.      Security Deposit. Concurrently with the execution and delivery of
this Second Amendment to Lessor, Lessee shall pay to Lessor the amount of Twenty Seven Thousand One Hundred Seven and No/100 Dollars ($27,107.00) to increase the Security Deposit being held by Lessor under the Lease. Upon Lessor’s receipt of
such amount, the Lease shall be amended by replacing all references to the existing amount of the Security Deposit with the amount of Eighty Thousand Four Hundred Thirty Two and 56/100 Dollars ($80,432.56), the increased amount of the Security
Deposit. 
 13.      HVAC for Suite 101 and Suite 103. Notwithstanding
anything to the contrary in the Lease, with respect to Suite 101, Suite 103 and the 10788 Building only, Lessor shall perform (and Lessee shall have no liability to perform) any maintenance, repair or replacements (including the obligation to
maintain service contracts pursuant to Section 7.1(b) of the Original Lease) to the heating, ventilating and air conditioning units serving the Premises or the Building. Any costs incurred by Lessor in connection with the prior sentence shall be
included in Common Area Operating Expenses, subject to the provisions of Section 7.1(d) of the Original Lease. 

14.      Estoppel. Lessee hereby certifies and acknowledges, that as of the
date hereof (a) to Lessee’s current, actual knowledge, Lessor is not in default in any respect under the Lease, (b) to Lessee’s current, actual knowledge, Lessee does not have any defenses to its obligations under the Lease, (c) Lessee has
paid to Lessor a Security Deposit in the amount of $53,325.56 under the Lease (subject to increase in accordance with Section 12 above), and (d) there are no offsets against rent payable under the Lease. Lessee acknowledges and agrees that: (i) the
representations herein set forth constitute a material consideration to Lessor in entering into this Second Amendment; (ii) such representations are being made by Lessee for purposes of inducing Lessor to enter into this Second Amendment; and (iii)
Lessor is relying on such representations in entering into this Second Amendment. Lessor hereby certifies and acknowledges, that as of the date hereof, to Lessor’s current, actual knowledge, Lessee is not in default in any respect under the
Lease. 
 15.      Brokers. Lessee hereby represents and warrants to
Lessor that Lessee has not entered into any agreement or taken any other action which might result in any obligation on the part of Lessor to pay any brokerage commission, finder’s fee or other compensation with respect to this Second
Amendment, other than to Hughes Marino and Cushman and Wakefield (the “Brokers”), and Lessee agrees to indemnify and hold Lessor harmless from and against any losses, damages, costs or expenses (including without limitation,
attorneys’ fees) incurred by Lessor by reason of any breach or inaccuracy of such representation or warranty. Lessor shall pay any fees or commissions owed to the Brokers pursuant to a separate written agreement. 

  

							
		 	6	 	Lessor’s Initials:	 	 MB

		 		 	Lessee’s Initials:	 	 BL

16.      Confidentiality.  Lessor and Lessee agree that the covenants and
provisions of this Second Amendment shall not be divulged to anyone not directly involved in the management, administration, ownership, lending against, sale or marketing or subleasing of the Premises, other than Lessee’s or Lessor’s
counsel or leasing or sub-leasing broker, accountants, financial advisors, lenders, investors, investment bankers, purchasers or any proposed assignee or sublessee, as required by law or in connection with any filing with the Securities and Exchange
Commission or any legal proceeding. 
 17.      Ratification.  Except
as otherwise specifically herein amended, the Lease is and shall remain in full force and effect according to the terms thereof. In the event of any conflict between the Lease and this Second Amendment, this Second Amendment shall control. 

18.      Attorneys’ Fees.  Should either party institute any action
or proceeding to enforce or interpret this Second Amendment or any provision thereof, for damages by reason of any alleged breach of this Second Amendment or of any provision hereof, or for a declaration of rights hereunder, the prevailing party in
any such action or proceeding shall be entitled to receive from the other party all cost and expenses, including actual attorneys’ and other fees, reasonably incurred in good faith by the prevailing party in connection with such action or
proceeding. The term “attorneys’ and other fees” shall mean and include attorneys’ fees, accountants’ fees, and any and all consultants’ and other similar fees incurred in connection with the action or proceeding and
preparations therefore. The term “action or proceeding” shall mean and include actions, proceedings, suits, arbitrations, appeals and other similar proceedings. 

19.      Submission.  Submission of this Second Amendment by Lessor to
Lessee for examination and/or execution shall not in any manner bind Lessor and no obligations on Lessor shall arise under this Second Amendment unless and until this Second Amendment is fully signed and delivered by Lessor and Lessee. 

20.      Counterparts.  This Second Amendment may be executed in several
counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same agreement. 

21.      Lender Approval.  Lessor represents and warrants that it has
obtained the written approval of its lender to this Second Amendment. 

22.      Signage.  Lessor, at Lessee’s sole expense, shall provide
all building standard suite identification signage in the lobby of the 10788 Building for Suite 103. 

23.      Parking. In addition to Lessee’s parking rights under the Lease with
respect to the Existing Premises, at no cost to Lessee, Lessee shall have the right to three (3) parking spaces per thousand rentable square feet of (a) Suite 101 from and after the Suite 101 Commencement Date, and (b) Suite 103 from and after the
Suite 103 Commencement Date. 

  

							
		 	7	 	Lessor’s Initials:	 	 MB

		 		 	Lessee’s Initials:	 	 BL

 IN WITNESS WHEREOF, this Second Amendment has been executed by the parties
as of the date first referenced above. 
  

											
		 	 “Lessor”
  
	 	
		 	 BRS-TUSTIN SAFEGUARD ASSOCIATES II, LLC,

a Delaware limited liability company
  

		 	By:	 	 Westcore Investments I, LLC
 a
Delaware limited liability company
 its Sole Member
  
	 	
		 		 	By:	 	 Westcore Properties, LLC
 a Delaware
limited liability company
 its Sole Member
  
	 	
		 		 		 	By:	 	    /s/ Matthew Bateman                 	 	
		 		 		 	Name:    Matthew Bateman                  	 	
		 		 		 	Title:   Authorized Signatory                	 	

  

							
		 	 “Lessee”
  
	 	
		 	PFENEX INC.,	 	
		 	a Delaware corporation	 	
				
		 	By:	 	    /s/ Bertrand C. Liang                  	 	
		 	Name:    Bertrand C.
Liang                            	 	
		 	Title:   CEO                              
                      	 	

  

							
		 	8	 	Lessor’s Initials:	 	 MB

		 		 	Lessee’s Initials:	 	 BL

 EXHIBIT A 

SITE PLAN OF SUITE 101 
  

 

  

							
		 	1	 	Lessor’s Initials:	 	 MB

		 		 	Lessee’s Initials:	 	 BL

 EXHIBIT B 

SITE PLAN OF SUITE 103 
  

 

  

							
		 	1	 	Lessor’s Initials:	 	 MB

		 		 	Lessee’s Initials:	 	 BLEX-10.20

 Exhibit 10.20 

CONFIDENTIAL TREATMENT REQUESTED 

CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. INFORMATION THAT WAS
OMITTED IN THE EDGAR VERSION HAS BEEN NOTED IN THIS DOCUMENT WITH A PLACEHOLDER IDENTIFIED BY THE MARK “[***]. 
  

											
	AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT	 	1. CONTRACT ID CODE	 	PAGE OF PAGES
	 		 	1	 	1

													
	2. AMENDMENT/MODIFICATION NO.  	 	3. EFFECTIVE DATE	 	4. REQUISITION/PURCHASE REQ. NO.  	 	5 PROJECT NO, (If applicable)    
	 0014
  
	 	 	 	See Block 16C	 	 	 	 	 	 
	5. ISSUED BY	 	CODE  	 	ASPR-BARDA	 	7. ADMINISTERED BY (If other than Item 6)	 	ASPR-BARDA02
	  
 ASPR-BARDA

200 Independence Ave., S.W.
 Room 640-G

Washington DC 20201
  
	 		 	  
 ASPR-BARDA

330 Independence Ave, SW, Rm G640
 Washington DC
20201
	 	
	 8. NAME AND ADDRESS OF CONTRACTOR (No., street, county,
State and ZIP code
  
 PFENEX, INC
1358378
 FENEX BIOPHARMACEUTICALS, INC.
 10790
ROSELLE ST
 SAN DIEGO CA 921211718
	 	  
 (x)
	 	 9A. AMENDMENT OF SOLICITATION NO.

 

	 	 	 	 9B. DATED (SEE ITEM 11)

 
  
	 	 	 	 
	 	x  	 	10A. MODIFICATION OF CONTRACT/ORDER NO.
	 		 	 HHSO100201000045C
  
	 		 	
	 		 	10B. DATED (SEE ITEM 13)
	 CODE 1358378

 
	 	 	 	 FACILITY CODE
  
	 		 	 07/30/2010
  
	 		 	

					
	11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
	The above numbered solicitation is amended as set forth in Item 14. The hour end date specified for receipt of Offers
                     is extended
                     is not extended. Offers must acknowledge receipt of this amendment prior to the hour and date specified in the
solicitation or as amended, by one of the following methods: (a) By completing Items 8 and 15, and returning          copies of the amendment; (b) By acknowledging receipt of this Amendment on
each copy of the offer submitted; or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO
THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes reference to the
solicitation and this amendment, and is received prior to the opening hour and date specified.
	12. ACCOUNTING AND APPROPRIATION. DATA (if required)
	See Schedule
	13. THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS/ORDERS. IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.
	 CHECK

ONE
	 	A.	  	THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.
	 	 	
	 	 	 	  	     
		 	B.	  	THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR
43.103(b).
	X	 	 	  	 
		 	C.	  	THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:
		 	    	  	
	 	 	D.	  	OTHER (Specify type of modification and authority)
	 	 	    	  	 
	  

E. IMPORTANT:    Contractor          is not X is required to sign
this document and return 1 copies to the issuing office
  

	 14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject
matter where feasible.)
 Tax ID Number:    27-1356759

DUNS Number:    013603710
 A. The
purpose of this modification is to transfer the inventory on the attached list from this expired contract HHS0100201000045C to active contract HHSO100201500011C.
  

SEE ATTACHED
  

B. This is a bilateral administrative no-cost modification. The total contract amount and all other terms and conditions remain the same.

Period of Performance: 07/30/2010 to 08/31/2015
 Except as
provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

							
	15A. NAME AND TITLE OF SIGNER (Type or print)	  	16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)
	Patrick Lucy - Chief Business Officer	  		  	THOMAS P. HASTINGS	  	
	15B. CONTRACTOR/OFFEROR	  	15C. DATE SIGNED	  	16B: UNITED STATES OF AMERICA	  	16C. DATE SIGNED
	  
 /s/ Patrick Lucy

(Signature of person authorized to sign)
	  	  
 10/19/15
	  	  
 /s/ Thomas P.
Hastings
 (Signature of Contracting Officer)
	  	  
 10/20/15

  

			
	NSN 7540-01-152-8070	  	STANDARD FORM 30 (REV. 10-83)
	Previous edition unusable	  	Prescribed by GSA
		  	FAR (48 CFR) 53.243

  
 [***] Certain information in this
document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

 

 
  

	 	1.	Inventory 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

  

			
	Pfenex Confidential	  	Page 1 of 6

 [***] 
  

																																							
	 item number
	  	 Description
	  	Concentration	 	 	Volume	 	 	Container	 	 	Lot #	 	 	Date of
Manuf.	 	 	Storage	 	 	Amount	 	 	Inventory
date	 	 	Storage
location	 
	 [***]
	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 

 [***] 

[***] 
  

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

  

			
	Pfenex Confidential	  	Page 2 of 6

 [***] 
  

																																							
	 Sentry item
number
	  	 Description
	  	Concentration	 	 	Volume	 	 	Container	 	 	Lot #	 	 	Date of
Manuf.	 	 	Storage	 	 	# Vials	 	 	Inventory
date	 	 	Storage
location	 
	 [***]
	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 	 	 	[***	] 

 [***] 
 [***] 

[***] 
  

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

  

			
	Pfenex Confidential	  	Page 3 of 6

 [***] 
  

																	
	 Reagent/Materials Name
	  	 mrPA lot/DOM
	  	 Description
	  	Amount left
(units)	 	 	Storage
Condition
(°C)	 	 	Date	 
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 

 [***] 
 [***] 

 

																	
	 Reagent/Materials Name
	  	 mrPA lot
	  	 Description
	  	Amount left
(units)	 	 	Storage
Condition
(°C)	 	 	Date	 
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
						
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
						
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
						
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 

  
 [***] Certain information in this document has been
omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

  

			
	Pfenex Confidential	  	Page 4 of 6

 [***] 
  

																	
	 Reagent/Materials Name
	  	 Lot
	  	 Description
	  	Amount left
(units)	 	 	Storage
Condition (°C)	 	 	Date	 
						
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 

 [***] 
  

																	
	 Reagent/Materials Name
	  	 Source
	  	 Description
	  	Amount left
(units)	 	 	Storage
Condition (°C)	 	 	Date	 
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
						
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
						
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 

 [***] 
  

																	
	 Reagent/Materials Name
	  	 Strain
	  	 Description
	  	Amount left
(units)	 	 	Storage
Condition (°C)	 	 	Date	 
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
						
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
						
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
						
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
						
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 

  
 [***] Certain information in this document has been
omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

  

			
	Pfenex Confidential	  	Page 5 of 6

																	
	 Reagent/Materials Name
	  	 	  	 Description
	  	Amount left
(units)	 	 	Storage
Condition (°C)	 	 	Date	 
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
						
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
						
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 

 [***] 
  

																	
	 Reagent/Materials Name
	  	 	  	 Description
	  	Amount left
(units)	 	 	Storage
Condition (°C)	 	 	Date	 
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 
	 [***]
	  	[***]	  	[***]	  	 	[***	] 	 	 	[***	] 	 	 	[***	] 

  
 [***] Certain information in this document has been
omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

  

			
	Pfenex Confidential	  	Page 6 of 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}]]